Life Summit hat dies direkt geteilt
𝗦𝘄𝗲𝗱𝗶𝘀𝗵 𝗵𝗲𝗮𝗹𝘁𝗵𝘁𝗲𝗰𝗵 𝗰𝗼𝗺𝗽𝗮𝗻𝘆 Neko Health 𝗵𝗮𝘀 𝗿𝗮𝗶𝘀𝗲𝗱 𝗮 $𝟳𝟬𝟬 𝗺𝗶𝗹𝗹𝗶𝗼𝗻 𝗦𝗲𝗿𝗶𝗲𝘀 𝗖 𝘁𝗼 𝗯𝗿𝗶𝗻𝗴 𝗶𝘁𝘀 𝗔𝗜-𝗽𝗼𝘄𝗲𝗿𝗲𝗱 𝗽𝗿𝗲𝘃𝗲𝗻𝘁𝗶𝘃𝗲 𝗵𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝗺𝗼𝗱𝗲𝗹 𝘁𝗼 𝘁𝗵𝗲 𝗨.𝗦. Neko Health raised a huge $700 million Series C. On the surface, the number barely adds up. Its 2025 revenue is estimated at around $18 million (CB Insights), which puts the valuation at roughly 400× estimated annual revenue. Which raises the question: why are investors willing to put this much capital behind a company like Neko Health? The answer could be a gap in the healthcare system itself. Modern healthcare is largely built to treat disease, not to proactively look for it. While you're healthy, the system mostly leaves you alone. Your doctor doesn't routinely perform a full-body scan at 40 because most healthcare systems reimburse diagnosis and treatment, not comprehensive preventive screening. That leaves millions unserved: healthy people who want to know what's happening inside their bodies before any symptoms appear. This is the gap whole-body imaging steps into 👇 ✅ 𝗜𝘁 𝗰𝗮𝘁𝗰𝗵𝗲𝘀 𝘀𝗶𝗴𝗻𝘀 𝗲𝗮𝗿𝗹𝘆 Cancers, cardiovascular risk, metabolic issues, often years before you'd feel anything. ✅ 𝗜𝘁 𝘀𝗲𝗿𝘃𝗲𝘀 not only people who are already sick Neko Health offers a 60-minute, comprehensive, non-invasive, and radiation-free health assessment also for those that are healthy by definition of the healthcare system. ✅ 𝗜𝘁 𝘀𝗰𝗮𝗹𝗲𝘀 𝗹𝗶𝗸𝗲 𝘀𝗼𝗳𝘁𝘄𝗮𝗿𝗲 One standardised scan, run the same way everywhere, cheaper the more people go through it. That last point is why the market prices Neko like a platform, not a clinic. Investors here are backing the potential the first touchpoint for preventive healthcare for millions of people to catch signs early. Long before a hospital ever gets involved. Here's what I keep coming back to, though. A nearly $7B valuation suggests investors believe prevention could reshape healthcare. But prevention only means something if it actually reaches people, not just those who can already afford it. Whether prevention can reach millions of people—not just those who can already afford it may ultimately matter even more than the technology itself. 𝗡𝗲𝗸𝗼 𝗮𝗹𝗿𝗲𝗮𝗱𝘆 𝗼𝗽𝗲𝗿𝗮𝘁𝗲𝘀 • 4 times in London • 1 in Manchester • 1 in Birmingham • 2 in Stockholm • New York opening in 2026 𝗕𝘂𝘁 𝘄𝗵𝗮𝘁 𝗮𝗯𝗼𝘂𝘁 𝘁𝗵𝗲 𝗗𝗔𝗖𝗛 𝗿𝗲𝗴𝗶𝗼𝗻? 𝗗𝗼 𝘆𝗼𝘂 𝘁𝗵𝗶𝗻𝗸 𝗚𝗲𝗿𝗺𝗮𝗻𝘆, 𝗦𝘄𝗶𝘁𝘇𝗲𝗿𝗹𝗮𝗻𝗱 𝗮𝗻𝗱 𝗔𝘂𝘀𝘁𝗿𝗶𝗮 𝗮𝗿𝗲 𝗿𝗲𝗮𝗱𝘆 𝗳𝗼𝗿 𝗮 𝗰𝗼𝗺𝗽𝗮𝗻𝘆 𝗹𝗶𝗸𝗲 𝗡𝗲𝗸𝗼 𝗛𝗲𝗮𝗹𝘁𝗵?